Tortoise Investment Management’s Novavax NVAX Stock Holding History

Tortoise Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25	Closed	-$316	–	884
2024 Q3	$316	Hold	25	–	–	﹤0.01%	848
2024 Q2	$317	Hold	25	–	–	﹤0.01%	853
2024 Q1	$120	Hold	25	–	–	﹤0.01%	853
2023 Q4	$120	Hold	25	–	–	﹤0.01%	773
2023 Q3	$181	Hold	25	–	–	﹤0.01%	778
2023 Q2	$186	Hold	25	–	–	﹤0.01%	752
2023 Q1	$173	Hold	25	–	–	﹤0.01%	751
2022 Q4	$257	Hold	25	–	–	﹤0.01%	747
2022 Q3	$0	Hold	25	–	–	﹤0.01%	766
2022 Q2	$1K	Hold	25	–	–	﹤0.01%	717
2022 Q1	$2K	Hold	25	–	–	﹤0.01%	642
2021 Q4	$4K	Hold	25	–	–	﹤0.01%	568
2021 Q3	$5K	Buy	+25	New	+$5.51K	﹤0.01%	528

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Tortoise Investment Management's NVAX Position: Q4 2024 in Review

Tortoise Investment Management sold out of Novavax (NVAX) in Q4 2024, closing a stake of 25 shares — an estimated $316 sold.

Tortoise Investment Management first reported a position in NVAX in Q3 2021 and held it in 13 quarters. The position peaked at $5K in Q3 2021. 234 funds tracked by Wall St. Rank hold NVAX as of Q4 2024.

Tortoise Investment Management reported no remaining Novavax position as of Q4 2024 after selling out during the quarter.
Tortoise Investment Management sold 25 Novavax shares in Q4 2024, an estimated $316.
Tortoise Investment Management first reported a position in Novavax in Q3 2021 and held it in 13 quarters.
Tortoise Investment Management's Novavax position peaked at $5K in Q3 2021.
234 funds tracked by Wall St. Rank held Novavax as of Q4 2024.

Based on Tortoise Investment Management's 13F filing for Q4 2024, filed 7 Feb 2025.